Standpack está comprometido con líderes mundiales en el campo del embalaje especial y con la producción de productos de la más alta calidad. Basados en la tecnología patentada y en los conocimientos prácticos recogidos a lo largo de los años, ofrecemos formas de maximizar la promoción de ventas para nuestros clientes más bien sólo vendiendo productos. Además, a través de la I+D continuas, estamos trabajando duro para desarrollar aplicaciones de patentes y materiales de embalaje funcionales para mantener el ritmo con las tendencias cambiantes del mercado y las NEEDS de los clientes. Avanzando, seguiremos construyendo la confianza de los clientes a través del desarrollo continuo de la tecnología y el control de calidad, y nos esforzaremos por proporcionar satisfacción a los clientes.
ST1 CO., LTD.
ST1 CO., LTD. manufacture nanofibers for 3D cell culture which attracts attention in basic bio research and new drug development after successfully developing commercialized nanofibers, using Polycaprolactone for the first time in Korea. We built electrospinning equipment with our own technology for uniform nanofibers. Especially, by technology of printing polymer frame on surface of nanofiber mat for free standing, we manufacture unique type of nanofibers. Apart from PCL, we are researching on biomaterial by utilization of various polymeric material such as PHEMA, PVA, Silk, Chitosan, Gelatin as well as Collagen. To expand our business to regenerative medicine, medical device by nanofibers, we are making effort to develop GBR membrane, artificial blood vessel, wound dressing etc. Also, we are working dentin/pulp regeneration research with our collaborating company.
ST Pharm
“ST Pharm provides reliable and timely custom manufacturing services for API following stringent quality system and close communication with the clients.” Founded in 1983, ST Pharm (formerly known as Samchully Pharmaceutical) has been offering excellent custom manufacturing services of APIs and their intermediates to meet clients’ high expectation for their use in pharmaceutical development in compliant to cGMP requirements. Our reliability in service, which is well-proven through decades of business relationship with many big pharmas and biotech clients, is the essence of our strength along with our expertise in process development and scale-up optimization. Historically, ST Pharm has been focusing our expertise on nucleoside based active pharmaceuticals in various antiviral drug applications; we became the world largest supplier of Thymidine in the late 1990s and Zidovudine in the mid 2000s and protected nucleosides in the early 2000s. ST Pharm has continuously been expanding its service offering, including synthesis of therapeutic oligonucleotides. In June 2010, ST Pharm became a subsidiary of Dong-A Pharmaceutical, the top pharmaceutical company in Korea. ST Pharm is committed to expanding its business scope into generic APIs and their intermediates with full support and collaboration with parent company Dong-A Pharmaceutical. #oligo #mRNA #CDMO #smallmolecule #CMO #rawmaterials | “ST Pharm provides reliable and timely custom manufacturing services for API following stringent quality system and close communication with the clients.” Founded in 1983, ST Pharm (formerly known as Samchully Pharmaceutical) has been offering excellent custom manufacturing services of APIs and their intermediates to meet clients’ high expectation for their use in pharmaceutical development in compliant to cGMP requirements. Our reliability in service, which is well-proven through decades of business relationship with many big pharmas and biotech clients, is the essence of our strength along with our expertise in process development and scale-up optimization. Historically, ST Pharm has been focusing our expertise on nucleoside based active pharmaceuticals in various antiviral drug applications; we became the world largest supplier of Thymidine in the late 1990s and Zidovudine in the mid 2000s and protected nucleosides in the early 2000s. ST Pharm has continuously been expanding its service offering, including synthesis of therapeutic oligonucleotides. In June 2010, ST Pharm became a subsidiary of Dong-A Pharmaceutical, the top pharmaceutical company in Korea. ST Pharm is committed to expanding its business scope into generic APIs and their intermediates with full support and collaboration with parent company Dong-A Pharmaceutical. #oligo #mRNA #gRNA #sgRNA #CDMO #smallmolecule #CMO #rawmaterials #LNP #Capping #conjugation | ST PHARM Co., Ltd. (“ST PHARM”) is a Contract Development and Manufacturing Organization (CDMO) providing phase-appropriate development and manufacturing services for APIs, intermediates, and target compounds to global pharmaceutical and biotech clients. It operates two cGMP-certified facilities in Sihwa and Banwol, with a strong track record of regulatory audits by agencies such as the US FDA, EMA, PMDA, TGA, ANVISA, MFDS, and WHO. With decades of expertise, ST PHARM has been a trusted supplier of small molecule new chemical entity (NCE) target compounds for antiviral drugs, including HIV, HBV, and HCV. It is particularly recognized for its leadership in nucleoside/tide chemistry-based pharmaceuticals. Leveraging this expertise, ST PHARM entered the oligonucleotide CDMO business in the early 2000s. Now among the top three global CDMOs in this field, it successfully launched commercial oligonucleotide therapeutics in 2022, with multiple Pre-Approval Inspections (PAIs) scheduled for 2024 and 2025. ST PHARM has also developed proprietary materials such as SmartCap® (a 5′-capping analog) and STLNP® (ionizable lipids for LNP formulations), essential for mRNA therapeutics. These innovations are supporting the commercialization of mRNA-based drugs. Additionally, ST PHARM is expanding its capabilities in circular RNA (circRNA) manufacturing to drive next-generation RNA therapeutics.
ST-Labs
ST-Labs, founded in 2021, develops short wave infrared (SWIR) spectrum analysis and AI solutions. With innovative, cost-effective technologies, the company drives sustainability through plastic analysis and recycling innovation, while expanding applications across agriculture, healthcare, and environmental fields.
SSCAN TECH
SSCAN TECH is a leading specialized manufacturer of can-making machinery with a 48-year history in Korea. The company designs and manufactures various can-making machines, including those for paint cans, aerosols, and drums, supplying them globally. Through continuous R&D and technological investment, it actively leads the future can-making machinery industry. Notably, the company focuses on developing secondary battery can production facilities, achieving significant productivity improvements.
SPS
SPS is a Korean company that develops Magconn technology and holds global intellectual property rights. We aim to standardize Magconn technology and are expanding application products by partnering with various companies around the world who want to use Magconn technology/module into their products & business
sPresto Co., Ltd
sPresto Co., Ltd. is an innovative information security company that addresses the issue of confidential corporate and government information leaks, as well as personal data breaches caused by illegal filming in offline spaces, through advanced display and optical lighting technology integrated with artificial intelligence.
Spotter Co., Ltd.
Spotter is a Physical AI company focused on intelligent automation for precision manufacturing. The company develops software-defined perception and control technologies that enable industrial and collaborative robots to adapt to real-world production variability.
SPILab Corporation
Raypann Drone is a self-adaptive AI drone platform that thinks about its own decisions. By combining a self-model with physics-based rules, it scores and explains each prediction, honestly signals when more data is needed, and adapts in real time to sensor failures and changing environments from edge to cloud for safe, reliable operation.
SPICO Corporation
Our company is located in Gimhae-si, Gyeongnam, Korea and is about 30 km away from Busan Port and Masan Port. Since the establishment in 1988, we have been manufacturing Pressure Vessel, Heat Exchanger, Lubrication Oil & Hydro Unit, and all employees are striving for the price, quality and delivery time that customers can satisfy.